Plain-English translation of NCT04976465 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is a real-world study of pregnant women with systemic lupus erythematosus (SLE)—an autoimmune disease that affects the whole body. Researchers are tracking how different lupus medications and treatments affect pregnancy outcomes for both you and your baby, and they're using a smart digital platform to help you stay connected with lupus specialists throughout your pregnancy.
Lupus can complicate pregnancy and increase the risk of miscarriage and other serious problems. Doctors need better information about which treatments work best and are safest during pregnancy, so this study is collecting real-world data on how pregnant women with lupus are being treated and what happens to their pregnancies.
You likely qualify if…
You likely don't qualify if…
You will use a digital platform to consult with lupus specialists and attend regular check-ins every 4 weeks from when your pregnancy is confirmed until delivery. During these visits, your doctors will monitor how your lupus and medications are affecting you and your baby. The study will track your pregnancy outcomes and compare results between women whose blood tests show different antibody patterns to help doctors understand what treatments work best.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
China